Roche ‘regulation’ is already in the Reuters lane - the edge is gone, and even direction is not resolved here
The Opportunity
The only reason this remains on the board at all is that “Roche + regulation” can matter when it is tied to a named asset, label change, or decision. But the lifecycle routing says the quiet part out loud: it is in propagation_monitor with a decaying edge and Tier-1 presence. Without a specific, hydrated regulator artefact or product linkage in this run, the system cannot even resolve direction, which is why it is MIXED and marked AVOID despite having a tradeable instrument.
The Timing
Market regime is Bullish 62/100. That backdrop supports longs, but here direction is MIXED and the edge is decaying, so timing is not the issue - specificity is. What would revive this is a concrete regulator decision document or company disclosure tied to a defined Roche programme that the market is mispricing. Absent that, this is a “monitor for incremental artefact” item, not an action item.
The Evidence
In this cycle, the propagation-monitor record flags Reuters as present in the coverage footprint (Tier-1) and explicitly notes the need to validate for primary regulator artefacts and specificity to a Roche asset. Hydrated source URLs are not provided for this signal in the 7A bundle (hydration_integrity is marked missing), so we cannot cite the underlying articles here. That absence is itself the reason for AVOID: we have mainstream propagation flags, but not the underlying proof package needed to trade it responsibly.